A carregar...
Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations
In patients with rheumatic diseases undergoing immunosuppressive treatment, hepatitis B virus reactivation (HBVr) has been long recognized as a major treatment-related adverse event with substantial morbidity and mortality. Because HBVr is easily preventable with appropriate screening and monitoring...
Na minha lista:
| Publicado no: | Ther Adv Musculoskelet Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7076579/ https://ncbi.nlm.nih.gov/pubmed/32206094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X20912646 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|